Dermira

Dermira

Dermira is a private, development-stage company focused on developing and commercializing innovative medical dermatology products for dermatologists and their patients.  The company’s portfolio of dermatology therapeutics includes DRM01, a topical sebum inhibitor for acne; DRM02, a topical PDE4 inhibitor for inflammatory skin diseases; DRM04, a topical treatment for hyperhidrosis; and DRM05, a topical photodynamic therapy for acne.  Dermira completed an initial public offering in October 2014.

< Back to Portfolios